Showing results (51-60 of 68) with videos related to
Sort By:
Pageof 7
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 29, 2016
[Treatment Continuation and Safety of Eribulin for the Treatment of Metastatic Breast Cancer]Shino Adachi, Eiseki Usami, Kazutomo Okada, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 21, 2012
[Tolerable evaluation for chemotherapy with S-1 plus cisplatin in elderly patients with advanced and recurrent gastric cancer]Michio Kimura, Eiseki Usami, Daisuke Ito, et al.Journal of Pharmacy Practice|January 29, 2013
Pharmaceutical care for patients undergoing s-1 plus Cisplatin therapy for unresectable recurrent gastric cancerMichio Kimura, Eiseki Usami, Tomoaki Yoshimura, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 14, 2018
The incidence and timing of leukocyte overshoot after pegfilgrastim administrationEiseki Usami, Michio Kimura, Mina Iwai, et al.Oncology|May 20, 2024
Relationship between Anaplastic Lymphoma Kinase Inhibitors and Epileptic Seizure Disorder: A Post-Marketing Surveillance StudyYoshihiro Noguchi, Hiroki Asano, Rikuto Masuda, et al.Oncology Letters|April 1, 2026
Effect of apalutamide dosage on the incidence of cutaneous adverse events and prostate-specific antigen reduction in patients with prostate cancerTakuya Matsuyama, Michio Kimura, Makiko Go, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 21, 2010
[Comparative safety evaluation of first- and second-line therapy with carboplatin + paclitaxel for advanced non-small cell lung cancer]Kazuyo Morihata, Michio Kimura, Kazutomo Okada, et al.American Journal of Infection Control|December 24, 2023
Evaluation of long-term pharmacist-led prospective audit and feedback in antimicrobial stewardship: An 8-year studyKengo Ohashi, Tomoko Matsuoka, Yasutaka Shinoda, et al.Oncology Letters|July 3, 2015
Adherence and awareness of the therapeutic intent of oral anticancer agents in an outpatient settingMichio Kimura, Keiji Nakashima, Eiseki Usami, et al.Molecular and Clinical Oncology|April 29, 2014
Safety and continuity of second- and third-line therapy with paclitaxel or irinotecan for advanced and recurrent gastric cancerMichio Kimura, Eiseki Usami, Tetsufumi Kanematsu, et al.Pageof 7